Marfan and other connective tissue disorders: Conservative and surgical considerations

Seminars in Vascular Surgery

Volumn 13, Issue 4, 2000, Pages 272-282

  Roseborough, Glen S ^a   Williams, G Melville ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA; ANEURYSM SURGERY; AORTA ANEURYSM; AORTA DISEASE; AORTA DISSECTION; AORTA RUPTURE; AORTA SURGERY; AORTA VALVE REGURGITATION; ARTICLE; CARDIOVASCULAR DISEASE; CONNECTIVE TISSUE DISEASE; EHLERS DANLOS SYNDROME; HEART DISEASE; HUMAN; MARFAN SYNDROME; PREVALENCE; PRIORITY JOURNAL; THORACIC AORTA;

AORTIC ANEURYSM; EHLERS-DANLOS SYNDROME; HUMANS; MARFAN SYNDROME; PREVALENCE;

EID: 0034490106     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Familial thoracic aortic dilatations and dissections: A case control study
2. Ehlers-Danlos syndromes
3. International nosology of heritable disorders of connective tissue, Berlin, 1986
4. Patients with Ehlers-Danlos syndrome type IV lack type III collagen
5. Clinical and genetic features of Ehlers-Danlos syndrome type IV - The vascular type
6. Spontaneous arterial perforation: The Ehlers-Danlos specter
7. Aortic disease associated with pregnancy
8. Dissection of the aorta in Turner's syndrome
9. Turner's syndrome associated with bicuspid aortic stenosis and dissecting aortic aneurysm
10. Aortic dilatation, dissection, and rupture in patients with Turner syndrome
11. Aortic dissection in Noonan's syndrome (46XY Turner)
12. Cardiovascular manifestations of pseudoxanthoma elasticum
13. Un cas de deformation congenitale des quatre membres, plus prononcee aux extremites, caracterisee par l'allongement des os avec un certain degre d'amincissement
14. Congenital aneurysmal dilatation of aorta associated with arachnodactyly
15. The cardiovascular aspects of Marfan syndrome: A heritable disorder of connective tissue
16. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils
17. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
18. Location on chromosome 15 of the gene defect causing Marfan syndrome
19. Life expectancy and causes of death in in the Marfan syndrome
20. Mitral valve dysfunction in the Marfan syndrome
21. Cardiac manifestations of Marfan syndrome in infancy and childhood
22. Surgical correction of cardiovascular deformities in Marfan's syndrome
23. Marfan's syndrome with aneurysms of ascending aorta and aortic regurgitation: Surgical treatment and new histochemical observations
24. The Marfan syndrome and cardiac surgery
25. Reoperations after operation on the thoracic aorta: Etiology, surgical techniques, and prevention
26. A technique for complete replacement of the ascending aorta
27. Eleven-year experience with composite replacement of the ascending aorta and the aortic valve
28. Aneurysms of cystic medionecrotic aortic root: A modified approach
29. Complete replacement of the ascending aorta with reimplantation of the coronary arteries
30. The Marfan syndrome: Surgical technique and follow-up in 50 patients
31. Surgical treatment of aneurysms of the ascending aorta in the Marfan syndrome: Results in 50 patients
32. Composite graft repair of Marfan aneurysm of 27 the ascending aorta: Results in 100 patients
33. Composite graft repair of Marfan aneurysm of the ascending aorta: Results in 150 patients
34. Sixteen year experience with aortic root replacement: Results of 172 operations
35. Composite valve graft replacement of the proximal aorta: Comparison of techniques in 348 patients
36. Impact of cardiovascular operation on survival in the Marfan patient
37. Long-term results with total replacement of the ascending aorta and reimplantation of the coronary arteries
38. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta
39. Results of a new conserving operation for treatment of aneurysms or acute dissection of the aortic root
40. Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root
41. Aortic valve sparing operations: An update
42. What is the appropriate size criterion for resection of thoracic aortic aneurysms?
43. Replacement of the aortic root in patients with the Marfan syndrome
44. Surgical treatment of the dilated ascending aorta: When and how?
45. Surgery of the thoracic aorta
46. Extensive aortic reconstruction for aortic aneurysms in Marfan syndrome
47. Marfan syndrome: Long-term survival and complications after aortic aneurysm repair
48. Surgical management of aortic dissection in patients in patients with the Marfan syndrome
49. Thoracoabdominal aorta in Marfan syndrome: MR imaging findings of progression of vasculopathy after surgical repair
50. Surgery for acute dissection of the ascending aorta. Should the arch be included?
51. When and how to include the arch repair in patients with acute dissection involving the ascending aorta
52. Surgical management of acute aortic dissection: New data
53. Four-year clinical experience with the gelatin-resorcin-formol biological glue in acute aortic dissection
54. Use of glue without graft replacement for type A dissections: A new surgical technique
55. Treatment of chronic expanding dissecting aortic aneurysms of the descending thoracic and upper abdominal aorta by extended aortotomy, removal of the dissected intima, and closure
56. Abdominal aortic tailoring for renal, visceral, and lower extremity malperfusion from acute aortic dissection
57. Progression of aortic dilatation and the benefit of beta-blockade in the Marfan syndrome
58. Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome
59. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome
60. Maternal and fetal complications of pregnancy
61. Life expectancy in the Marfan syndrome